nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.383	1	CbGbCtD
L-Carnitine—SLC22A16—kidney—focal segmental glomerulosclerosis	0.0284	0.0849	CbGeAlD
L-Carnitine—SLC22A8—nephron—focal segmental glomerulosclerosis	0.0279	0.0832	CbGeAlD
L-Carnitine—CROT—nephron tubule—focal segmental glomerulosclerosis	0.0234	0.0698	CbGeAlD
L-Carnitine—SLC25A20—nephron tubule—focal segmental glomerulosclerosis	0.0203	0.0607	CbGeAlD
L-Carnitine—CROT—cortex of kidney—focal segmental glomerulosclerosis	0.02	0.0597	CbGeAlD
L-Carnitine—CRAT—nephron tubule—focal segmental glomerulosclerosis	0.0197	0.0589	CbGeAlD
L-Carnitine—SLC25A20—cortex of kidney—focal segmental glomerulosclerosis	0.0174	0.052	CbGeAlD
L-Carnitine—CRAT—kidney—focal segmental glomerulosclerosis	0.0173	0.0518	CbGeAlD
L-Carnitine—CRAT—Fatty Acid Beta Oxidation—LIPC—focal segmental glomerulosclerosis	0.0173	0.0837	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty Acid Beta Oxidation—LIPC—focal segmental glomerulosclerosis	0.0173	0.0837	CbGpPWpGaD
L-Carnitine—CRAT—cortex of kidney—focal segmental glomerulosclerosis	0.0169	0.0504	CbGeAlD
L-Carnitine—MPO—endothelium—focal segmental glomerulosclerosis	0.0164	0.0491	CbGeAlD
L-Carnitine—CPT2—nephron tubule—focal segmental glomerulosclerosis	0.0152	0.0453	CbGeAlD
L-Carnitine—CPT1A—kidney—focal segmental glomerulosclerosis	0.0141	0.042	CbGeAlD
L-Carnitine—CPT2—kidney—focal segmental glomerulosclerosis	0.0133	0.0398	CbGeAlD
L-Carnitine—CPT2—cortex of kidney—focal segmental glomerulosclerosis	0.013	0.0388	CbGeAlD
L-Carnitine—CPT2—Fatty Acid Beta Oxidation—LIPC—focal segmental glomerulosclerosis	0.0111	0.0539	CbGpPWpGaD
L-Carnitine—CRAT—Fatty Acid Beta Oxidation—LPL—focal segmental glomerulosclerosis	0.0105	0.051	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty Acid Beta Oxidation—LPL—focal segmental glomerulosclerosis	0.0105	0.051	CbGpPWpGaD
L-Carnitine—XDH—kidney—focal segmental glomerulosclerosis	0.0104	0.031	CbGeAlD
L-Carnitine—XDH—Effects of Nitric Oxide—NOS2—focal segmental glomerulosclerosis	0.00775	0.0375	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty Acid Beta Oxidation—LIPC—focal segmental glomerulosclerosis	0.00771	0.0374	CbGpPWpGaD
L-Carnitine—SLC22A4—nephron tubule—focal segmental glomerulosclerosis	0.00688	0.0205	CbGeAlD
L-Carnitine—SLCO1B1—kidney—focal segmental glomerulosclerosis	0.00681	0.0203	CbGeAlD
L-Carnitine—CPT2—Fatty Acid Beta Oxidation—LPL—focal segmental glomerulosclerosis	0.00679	0.0329	CbGpPWpGaD
L-Carnitine—MPO—kidney—focal segmental glomerulosclerosis	0.00662	0.0198	CbGeAlD
L-Carnitine—SLC22A4—kidney—focal segmental glomerulosclerosis	0.00604	0.018	CbGeAlD
L-Carnitine—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.00602	0.018	CbGeAlD
L-Carnitine—SLC22A4—cortex of kidney—focal segmental glomerulosclerosis	0.00589	0.0176	CbGeAlD
L-Carnitine—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00529	0.07	CcSEcCtD
L-Carnitine—SLC22A8—kidney—focal segmental glomerulosclerosis	0.00529	0.0158	CbGeAlD
L-Carnitine—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.00515	0.0154	CbGeAlD
L-Carnitine—CPT1A—Fatty Acid Beta Oxidation—LPL—focal segmental glomerulosclerosis	0.00471	0.0228	CbGpPWpGaD
L-Carnitine—SLC22A5—nephron tubule—focal segmental glomerulosclerosis	0.00455	0.0136	CbGeAlD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00401	0.0194	CbGpPWpGaD
L-Carnitine—SLC22A5—kidney—focal segmental glomerulosclerosis	0.004	0.0119	CbGeAlD
L-Carnitine—SLC22A5—cortex of kidney—focal segmental glomerulosclerosis	0.00389	0.0116	CbGeAlD
L-Carnitine—CPT2—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.00383	0.0186	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00375	0.0182	CbGpPWpGaD
L-Carnitine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.0469	CcSEcCtD
L-Carnitine—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.0405	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.0378	CcSEcCtD
L-Carnitine—SLCO1B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.00266	0.0129	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.00265	0.0129	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—NOS2—focal segmental glomerulosclerosis	0.0026	0.0126	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.0026	0.0126	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00258	0.0125	CbGpPWpGaD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.00251	0.0122	CbGpPWpGaD
L-Carnitine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.0325	CcSEcCtD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.00238	0.0115	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00227	0.011	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.00222	0.0108	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00213	0.0103	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	0.00211	0.0102	CbGpPWpGaD
L-Carnitine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.0265	CcSEcCtD
L-Carnitine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.0264	CcSEcCtD
L-Carnitine—SLCO1B1—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.00197	0.00954	CbGpPWpGaD
L-Carnitine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0248	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00188	0.00909	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00181	0.00878	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00181	0.00878	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00179	0.00867	CbGpPWpGaD
L-Carnitine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.0235	CcSEcCtD
L-Carnitine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0234	CcSEcCtD
L-Carnitine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.023	CcSEcCtD
L-Carnitine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0226	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.0017	0.00822	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.00169	0.0082	CbGpPWpGaD
L-Carnitine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.0224	CcSEcCtD
L-Carnitine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0216	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.0016	0.00773	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.0016	0.00773	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00157	0.00763	CbGpPWpGaD
L-Carnitine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0208	CcSEcCtD
L-Carnitine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0207	CcSEcCtD
L-Carnitine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0207	CcSEcCtD
L-Carnitine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0205	CcSEcCtD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.00154	0.00746	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.00153	0.00742	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00151	0.00731	CbGpPWpGaD
L-Carnitine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0188	CcSEcCtD
L-Carnitine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0185	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00138	0.00669	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—ALB—focal segmental glomerulosclerosis	0.00138	0.00667	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.00137	0.00663	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00136	0.00661	CbGpPWpGaD
L-Carnitine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0176	CcSEcCtD
L-Carnitine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.0173	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.0013	0.0063	CbGpPWpGaD
L-Carnitine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0166	CcSEcCtD
L-Carnitine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0162	CcSEcCtD
L-Carnitine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0157	CcSEcCtD
L-Carnitine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0156	CcSEcCtD
L-Carnitine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.0155	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00117	0.00566	CbGpPWpGaD
L-Carnitine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0153	CcSEcCtD
L-Carnitine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0153	CcSEcCtD
L-Carnitine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0153	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00111	0.00539	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.00111	0.00537	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00111	0.00536	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00111	0.00536	CbGpPWpGaD
L-Carnitine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0146	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.0011	0.00531	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00109	0.0053	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.00106	0.00514	CbGpPWpGaD
L-Carnitine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.014	CcSEcCtD
L-Carnitine—SLCO1B1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.00103	0.00499	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00103	0.00498	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0134	CcSEcCtD
L-Carnitine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0133	CcSEcCtD
L-Carnitine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000997	0.0132	CcSEcCtD
L-Carnitine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00099	0.0131	CcSEcCtD
L-Carnitine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000986	0.00477	CbGpPWpGaD
L-Carnitine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000977	0.0129	CcSEcCtD
L-Carnitine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000965	0.0128	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000959	0.0127	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000958	0.00464	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000957	0.00463	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00095	0.0046	CbGpPWpGaD
L-Carnitine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000949	0.0126	CcSEcCtD
L-Carnitine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000949	0.0126	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000947	0.00458	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000947	0.00458	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000908	0.012	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000887	0.0043	CbGpPWpGaD
L-Carnitine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000878	0.0116	CcSEcCtD
L-Carnitine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000878	0.0116	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000854	0.00414	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000836	0.00405	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000818	0.0108	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00081	0.00392	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000807	0.00391	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000807	0.00391	CbGpPWpGaD
L-Carnitine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000797	0.0105	CcSEcCtD
L-Carnitine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.0104	CcSEcCtD
L-Carnitine—CROT—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00077	0.00373	CbGpPWpGaD
L-Carnitine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00076	0.0101	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000747	0.00362	CbGpPWpGaD
L-Carnitine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000734	0.00971	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000726	0.00352	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000726	0.00352	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000713	0.00345	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000713	0.00345	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000711	0.00344	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000711	0.00344	CbGpPWpGaD
L-Carnitine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.00934	CcSEcCtD
L-Carnitine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.0007	0.00926	CcSEcCtD
L-Carnitine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000699	0.00925	CcSEcCtD
L-Carnitine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000696	0.0092	CcSEcCtD
L-Carnitine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00873	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000655	0.00317	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000655	0.00317	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00061	0.00295	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—LPL—focal segmental glomerulosclerosis	0.000579	0.00281	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000563	0.00273	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00052	0.00252	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000505	0.00244	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000497	0.00241	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AGT—focal segmental glomerulosclerosis	0.000496	0.0024	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000494	0.00239	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—LPL—focal segmental glomerulosclerosis	0.000493	0.00239	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—LPL—focal segmental glomerulosclerosis	0.000493	0.00239	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000468	0.00227	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000458	0.00222	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000423	0.00205	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000422	0.00204	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AGT—focal segmental glomerulosclerosis	0.000422	0.00204	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AGT—focal segmental glomerulosclerosis	0.000422	0.00204	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.00041	0.00199	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ALB—focal segmental glomerulosclerosis	0.00038	0.00184	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000379	0.00184	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000361	0.00175	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000343	0.00166	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000324	0.00157	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALB—focal segmental glomerulosclerosis	0.000323	0.00157	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALB—focal segmental glomerulosclerosis	0.000323	0.00157	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000318	0.00154	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000318	0.00154	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000308	0.00149	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000293	0.00142	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000282	0.00137	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000279	0.00135	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000272	0.00132	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00026	0.00126	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000249	0.0012	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000239	0.00116	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—LPL—focal segmental glomerulosclerosis	0.00022	0.00107	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000212	0.00103	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00021	0.00102	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000208	0.00101	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000208	0.00101	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000194	0.000939	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000188	0.000912	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000172	0.000835	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000157	0.000759	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000147	0.000714	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—LPL—focal segmental glomerulosclerosis	0.000146	0.000706	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000144	0.0007	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000142	0.000686	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000126	0.000609	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AGT—focal segmental glomerulosclerosis	0.000125	0.000604	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000113	0.000548	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000111	0.000536	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000108	0.000521	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000102	0.000494	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—focal segmental glomerulosclerosis	9.57e-05	0.000464	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LPL—focal segmental glomerulosclerosis	7.67e-05	0.000372	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AGT—focal segmental glomerulosclerosis	6.56e-05	0.000318	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—focal segmental glomerulosclerosis	5.04e-05	0.000244	CbGpPWpGaD
